<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03164668</url>
  </required_header>
  <id_info>
    <org_study_id>1609M94682</org_study_id>
    <nct_id>NCT03164668</nct_id>
  </id_info>
  <brief_title>Menthol Flavored E-cigarette Use During a Simulated Ban of Menthol Cigarettes</brief_title>
  <official_title>Menthol Flavored E-cigarette Use During a Simulated Ban of Menthol Cigarettes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this formative study is to provide preliminary data regarding how the
      availability of menthol flavored e-cigarettes affects tobacco use behavior in the context of
      a ban on menthol flavored cigarettes
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 3, 2017</start_date>
  <completion_date type="Actual">September 1, 2019</completion_date>
  <primary_completion_date type="Actual">September 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of cigarettes smoked</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>number of e-cigarettes used</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>Usual cigs; menthol e-cig then tobacco e-cigs</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants can continue to smoke their usual cigarettes. For the first month of study they receive menthol flavored e-cigarettes and for the second month they receive tobacco flavored e-cigarettes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual cigs; tobacco e-cig then menthol e-cigs</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants can continue to smoke their usual cigarettes. For the first month of study they receive tobacco flavored e-cigarettes and for the second month they receive menthol flavored e-cigarettes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>avoid menthol cigs; menthol e-cig then tobacco e-cigs</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants avoid smoking menthol cigarettes. For the first month of study they receive menthol flavored e-cigarettes and for the second month they receive tobacco flavored e-cigarettes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>avoid menthol cigs; tobacco e-cig then menthol e-cigs</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants avoid smoking menthol cigarettes. For the first month of study they receive tobacco flavored e-cigarettes and for the second month they receive menthol flavored e-cigarettes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>menthol flavored e-cigarette</intervention_name>
    <description>menthol flavored e-cigarette</description>
    <arm_group_label>Usual cigs; menthol e-cig then tobacco e-cigs</arm_group_label>
    <arm_group_label>Usual cigs; tobacco e-cig then menthol e-cigs</arm_group_label>
    <arm_group_label>avoid menthol cigs; menthol e-cig then tobacco e-cigs</arm_group_label>
    <arm_group_label>avoid menthol cigs; tobacco e-cig then menthol e-cigs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>tobacco flavored e-cigarette</intervention_name>
    <description>tobacco flavored e-cigarette</description>
    <arm_group_label>Usual cigs; menthol e-cig then tobacco e-cigs</arm_group_label>
    <arm_group_label>Usual cigs; tobacco e-cig then menthol e-cigs</arm_group_label>
    <arm_group_label>avoid menthol cigs; menthol e-cig then tobacco e-cigs</arm_group_label>
    <arm_group_label>avoid menthol cigs; tobacco e-cig then menthol e-cigs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Self identify as African American

          -  smoke primarily menthol cigarettes

          -  be between the ages of 18 and 64

          -  smoke a minimum number of cigarettes per day

          -  agree to abstain from menthol cigarettes for an 8 week period

        Exclusion Criteria:

          -  current unstable medical / psychiatric condition

          -  regular use any form of nicotine or tobacco other than cigarettes

          -  are pregnant or breast feeding

        The investigators will evaluate if there are other reasons why someone may not be eligible
        to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinical and Translational Sciences Institute</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>May 22, 2017</study_first_submitted>
  <study_first_submitted_qc>May 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2017</study_first_posted>
  <last_update_submitted>October 28, 2019</last_update_submitted>
  <last_update_submitted_qc>October 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

